Plain-English translation of NCT05612100 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is following women with breast cancer who are taking hormone therapy to understand how often and how severely hair loss occurs. Researchers want to compare hair loss across different types of hormone treatments—including tamoxifen, aromatase inhibitors, and combinations with other drugs—to learn more about this side effect and help future patients know what to expect.
Hair loss is a side effect that can happen with hormone therapy for breast cancer, but we don't have clear information about how common it is, how bad it gets, or how it differs between different medications. This study will help doctors better understand and prepare patients for this experience.
You likely qualify if…
You likely don't qualify if…
You will complete questionnaires about your hair loss every 3 months throughout your treatment. Researchers will also review your medical records. The study involves no extra office visits or medical procedures—just filling out surveys about how your hair is doing. You can complete the questionnaires yourself or with help if needed.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
United States